Celldex Therapeutics, Inc. of HAMPTON, NJ filed a DEF 14A with the SEC on 2023-04-25. Industry: In Vitro & In Vivo Diagnostic Substances.
| Seq | Type | Description |
|---|---|---|
| 1 | DEF 14A | DEF 14A |
| 2 | EX-101.SCH | XBRL TAXONOMY EXTENSION SCHEMA |
| 3 | EX-101.DEF | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE |
| 4 | EX-101.LAB | XBRL TAXONOMY EXTENSION LABEL LINKBASE |
| 5 | EX-101.PRE | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE |
| 6 | GRAPHIC | GRAPHIC |
| 7 | GRAPHIC | GRAPHIC |
| 8 | GRAPHIC | GRAPHIC |
| 9 | GRAPHIC | GRAPHIC |
| 10 | GRAPHIC | GRAPHIC |
| 13 | XML | EXTRACTED XBRL INSTANCE DOCUMENT |
Showing 12 of 49 filings.
| Filed | Form |
|---|---|
| 2026-04-29 | DEF 14A |
| 2025-04-21 | DEF 14A |
| 2024-04-25 | DEF 14A |
| 2023-04-25 | DEF 14A |
| 2022-04-26 | DEF 14A |
| 2021-04-27 | DEF 14A |
| 2020-04-28 | DEF 14A |
| 2019-05-07 | DEFA14A |
| 2019-04-26 | DEF 14A |
| 2018-04-30 | DEF 14A |
| 2018-04-19 | PRE 14A |
| 2017-04-28 | DEF 14A |